Question 1

What are the potential benefits of this treatment for my specific situation?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from CPX-351 and midostaurin?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the process be for the stem cell transplant after this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

Question 6

What support is available for managing side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia clinical trial (NCT04982354). Contact the study team or your healthcare provider for specific answers.

What this study is about